文献速递脑血管病外科神经重症

动脉瘤性蛛网膜下腔出血早期临床病程:WEB、夹闭与栓塞比较

Early clinical course after aneurysmal subarachnoid hemorrhage: comparison of patients treated with Woven EndoBridge, microsurgical clipping, or endovascular coiling.
PubMed 文献 · Acta Neurochir (Wien) · 2019-07-06

该回顾性队列分析纳入2015年3月至2018年8月201例证实SAH患者,比较WEB装置(38例)、弹簧圈栓塞(107例)与显微外科夹闭(56例)的早期临床病程;总体死亡率为17.9%,Hunt-Hess分级而非治疗方式为ICU死亡的独立危险因素(p<0.001)。

要点

  • WEB组与栓塞组、夹闭组早期临床病程无差异。
  • Hunt-Hess分级是ICU死亡的独立危险因素(p<0.001)。

核心结论

  • WEB栓塞、弹簧圈栓塞与显微外科夹闭三组患者的早期临床病程无差异。
  • WEB栓塞可作为弹簧圈栓塞的有价值替代方案,不应将WEB排除在后续SAH临床试验之外。

研究设计与样本

  • 回顾性分析未选择患者队列,系统回顾2015年3月至2018年8月期间证实的SAH患者数据。
  • 共纳入201例患者,其中弹簧圈栓塞107例、夹闭56例、WEB装置38例。

主要发现

  • 总体死亡率为17.9%。
  • 各治疗组间重要医学因素无临床相关差异,所分析血液参数大多在生理范围内。
  • Hunt-Hess分级而非治疗方式是整体队列中与ICU死亡相关的独立危险因素(p<0.001)。

临床怎么用

  • 对于SAH后颅内动脉瘤,WEB栓塞可作为与弹簧圈栓塞相当的早期治疗选择。
  • 评估SAH患者ICU死亡风险时,Hunt-Hess分级是独立危险因素。

局限性

  • WEB组的长期临床结局、动脉瘤闭塞率及再治疗率需进一步研究分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Woven EndoBridge (WEB) device has been increasingly used for the treatment of intracranial aneurysms after aneurysmal subarachnoid hemorrhage (SAH). Still, recent major clinical trials on patient management after SAH have defined WEB embolization as an exclusion criterion. In an analysis of an unselected patient cohort, we evaluate the early clinical course of SAH patients after WEB treatment compared to those treated with endovascular coiling or surgical clipping. METHODS: Data of all patients with proven SAH who were either treated with a WEB device, coil embolization, or neurosurgical clipping between March 2015 and August 2018 was systematically reviewed. Clinical parameters on intensive care unit (ICU), medical history and mortality rates were evaluated and compared between the different treatment approaches. RESULTS: Of all 201 patients included, 107 patients received endovascular coil embolization, 56 patients were treated with clipping and in 38 cases a WEB device was placed. The overall mortality was 17.9%. Thirteen patients (34.2%) in the WEB group had a Hunt and Hess grade > 3. Essential medical factors showed no clinically relevant differences between the treatment groups, and the analyzed blood parameters were predominantly within physiological limits without any relevant outliers. The Hunt and Hess grade but not the treatment modality was identified as independent risk-factor associated with ICU-mortality in the overall cohort (p < 0.001). CONCLUSION: In this study, there was no difference in the early clinical course between those treated with WEB embolization, coil embolization, or neurosurgical clipping. Since WEB embolization is a valuable treatment alternative to coiling, it seems not justified to exclude this procedure from upcoming clinical SAH trials, yet the clinical long-term outcome, aneurysm occlusion, and retreatment rates have to be analyzed in further studies. CLINICAL TRIAL REGISTRATION NUMBER: not applicable.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Sauvigny T, Nawka MT, Schweingruber N, et al. Early clinical course after aneurysmal subarachnoid hemorrhage: comparison of patients treated with Woven EndoBridge, microsurgical clipping, or endovascular coiling. Acta Neurochir (Wien). 2019. PMID: 31280480. doi:10.1007/s00701-019-03992-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。